{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:07:39Z","timestamp":1789049259268,"version":"build-2803163510"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304308"],"award-info":[{"award-number":["82304308"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574257"],"award-info":[{"award-number":["82574257"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Wenzhou Basic Medical and Health Technology Project","doi-asserted-by":"publisher","award":["Y20220202"],"award-info":[{"award-number":["Y20220202"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Wenzhou Basic Medical and Health Technology Project","doi-asserted-by":"publisher","award":["Y2023180"],"award-info":[{"award-number":["Y2023180"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Platelet-derived growth factor receptors (PDGFRs), recognized as key oncogenic drivers in hepatocellular carcinoma (HCC), play crucial roles in regulating cancer cell proliferation, differentiation and migration. Although PDGFR\u03b2 is implicated in HCC progression, highly selective PDGFR\u03b2 inhibitors are still scarce. Herein, we report the discovery of novel and selective PDGFR\u03b2 inhibitors A42, A43, A45, and A46 through structure-based optimization. Among these, A45 showed the highest selectivity, with a selectivity factor of 20.7. Based on cellular antiproliferative activity and cytotoxicity profiles, the moderately selective compound A42 was selected for further investigation. A42 significantly inhibited the proliferation, colony formation and migration of HCC cells and induced substantial apoptosis. Furthermore, A42 demonstrated a favorable safety profile and promising pharmacokinetic properties with an oral bioavailability of 43.47% and significantly inhibited tumor growth in the Huh-7 xenograft tumor model. Collectively, these results suggest that A42 may serve as a promising therapeutic candidate for HCC treatment.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c03028","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:54:23Z","timestamp":1783648463000},"page":"20091-20115","source":"Crossref","is-referenced-by-count":0,"title":["Discovery,\nOptimization,\nand Evaluation of Potent\nand Selective PDGFR\u03b2 Inhibitors for the Treatment of Hepatocellular\nCarcinoma"],"prefix":"10.1021","volume":"69","author":[{"given":"Dalong","family":"Wang","sequence":"first","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Wang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[{"name":"Zhejiang Xiaoshan Hospital , , ,","place":["Hangzhou, Zhejiang, People\u2019s Republic of China, 311200"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Guan","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinke","family":"Yuan","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youshuo","family":"Zang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-1209","authenticated-orcid":true,"given":"Xiaohui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8986-4427","authenticated-orcid":true,"given":"Zhiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University , , , ,","place":["Wenzhou, Zhejiang, People\u2019s Republic of China, 325035"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"1","key":"2026091009074375800_cit1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated\nmacrophages, extracellular matrix proteins, and cancer-associated\nfibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"2026091009074375800_cit2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1429919","article-title":"Exploring\npotential predictive biomarkers through historical perspectives on\nthe evolution of systemic therapies into the emergence of neoadjuvant\ntherapy for the treatment of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"issue":"6801","key":"2026091009074375800_cit3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in\ncancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"1","key":"2026091009074375800_cit4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic\nadvances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"issue":"5","key":"2026091009074375800_cit5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/pin.12530","article-title":"Pathogenetic significance\nand possibility as a therapeutic target of platelet derived growth\nfactor","volume":"67","author":"Ishii","year":"2017","journal-title":"Pathol. Int."},{"issue":"2","key":"2026091009074375800_cit6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11481-013-9484-2","article-title":"Targeting\nthe PDGF signaling pathway in the treatment of non-malignant diseases","volume":"9","author":"Heldin","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"2026091009074375800_cit7","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1250533","article-title":"Growth factors in the treatment of\nAchilles tendon injury","volume":"11","author":"Lin","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"2026091009074375800_cit8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted\ntherapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol.\nMed."},{"issue":"3","key":"2026091009074375800_cit9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGFRs\nare critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2026091009074375800_cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155462","article-title":"Andrographolide\nsensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting\nthe EGFR\/AKT and PDGFR\u03b2\/AKT signaling pathways","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"2026091009074375800_cit11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41416-020-0905-8","article-title":"Regorafenib is effective\nagainst\nneuroblastoma in vitro and in vivo and inhibits the RAS\/MAPK, PI3K\/Akt\/mTOR\nand Fos\/Jun pathways","volume":"123","author":"Subramonian","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"20","key":"2026091009074375800_cit12","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1007\/s00018-014-1599-y","article-title":"miR-34a regulates mesangial cell\nproliferation via the PDGFR-\u03b2\/Ras-MAPK signaling pathway","volume":"71","author":"Chen","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"2026091009074375800_cit13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11864-025-01350-4","article-title":"Dermatofibrosarcoma Protuberans (DFSP):\nDiagnostics and Molecular Pathology","volume":"26","author":"Remiszewski","year":"2025","journal-title":"Curr. Treat\nOpt. Oncol."},{"issue":"1","key":"2026091009074375800_cit14","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01040-7","article-title":"Somatic PDGFRB\nactivating variants promote smooth muscle\ncell phenotype modulation in intracranial fusiform aneurysm","volume":"31","author":"Hao","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"2026091009074375800_cit15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68068-1","article-title":"Tensile force-induced PDGF-BB\/PDGFR\u03b2 signals in periodontal\nligament fibroblasts activate JAK2\/STAT3 for orthodontic tooth movement","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"2026091009074375800_cit16","doi-asserted-by":"publisher","DOI":"10.3390\/md17070421","article-title":"Selective Suppression of Cell Growth and Programmed\nCell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low\nMolecular Weight Fucoidan Extract","volume":"17","author":"Teruya","year":"2019","journal-title":"Mar. Drugs"},{"issue":"1","key":"2026091009074375800_cit17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59938-1","article-title":"PDGFR\u03b1\/\u03b2\nheterodimer activation negatively\naffects downstream ERK1\/2 signaling and cellular proliferation","volume":"16","author":"Campan\u0303a","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091009074375800_cit18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","article-title":"Targeting the PDGF\/PDGFR signaling\npathway for cancer therapy: A review","volume":"202","author":"Zou","year":"2022","journal-title":"Int. J.\nBiol. Macromol."},{"issue":"1","key":"2026091009074375800_cit19","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-32-16","article-title":"Expression\nand prognostic value of VEGFR-2, PDGFR-\u03b2, and c-Met in advanced\nhepatocellular carcinoma","volume":"32","author":"Chu","year":"2013","journal-title":"J. Exp. Clin. Cancer\nRes."},{"issue":"3","key":"2026091009074375800_cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100159","article-title":"The EMA assessment\nof avapritinib in the treatment of gastrointestinal stromal tumours\nharbouring the PDGFRA D842V mutation","volume":"6","author":"Trullas-Jimeno","year":"2021","journal-title":"ESMO Open"},{"issue":"19","key":"2026091009074375800_cit21","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43\u20139006 exhibits broad\nspectrum oral antitumor\nactivity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine\nkinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"2026091009074375800_cit22","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.23131","article-title":"E7080, a novel inhibitor\nthat targets multiple kinases, has potent antitumor activities against\nstem cell factor producing human small cell lung cancer H146, based\non angiogenesis inhibition","volume":"122","author":"Matsui","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"1","key":"2026091009074375800_cit23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ijc.25864","article-title":"Regorafenib (BAY 73\u20134506):\na new oral multikinase inhibitor of angiogenic, stromal and oncogenic\nreceptor tyrosine kinases with potent preclinical antitumor activity","volume":"129","author":"Wilhelm","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"2","key":"2026091009074375800_cit24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.canlet.2016.01.014","article-title":"Apatinib: A novel receptor\ntyrosine kinase inhibitor for the treatment of gastric cancer","volume":"372","author":"Roviello","year":"2016","journal-title":"Cancer Lett."},{"issue":"11","key":"2026091009074375800_cit25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112798","article-title":"Emerging Therapies\nfor Hepatocellular Carcinoma (HCC)","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"2026091009074375800_cit26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11523-024-01067-8","article-title":"Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities\nAmong Cancer Patients: A Systematic Review and Meta-Analysis","volume":"19","author":"Van Nguyen","year":"2024","journal-title":"Targeted Oncol."},{"issue":"6","key":"2026091009074375800_cit27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11888-015-0292-3","article-title":"Update on Anti-Angiogenesis\nTherapy in Colorectal Cancer","volume":"11","author":"Ciombor","year":"2015","journal-title":"Curr. Colorectal.\nCancer Rep."},{"key":"2026091009074375800_cit28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1446945","article-title":"Efficacy and\nsafety of regorafenib for the treatment of metastatic colorectal cancer\nin routine clinical practice: results from a Spanish hospital","volume":"14","author":"Rubio","year":"2024","journal-title":"Front. Oncol."},{"key":"2026091009074375800_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117343","article-title":"Recent advancements\nin the small-molecule\ndrugs for hepatocellular carcinoma (HCC): Structure-activity relationships,\npharmacological activities, and the clinical trials","volume":"179","author":"Deng","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"2026091009074375800_cit30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa\nin metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl.\nJ. Med."},{"issue":"11","key":"2026091009074375800_cit31","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1200\/JCO.22.02623","article-title":"Overall\nSurvival and Updated Results for Sunitinib Compared With Interferon\nAlfa in Patients With Metastatic Renal Cell Carcinoma","volume":"41","author":"Motzer","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026091009074375800_cit32","first-page":"327","article-title":"In vivo\nantitumor activity of SU11248,\na novel tyrosine kinase inhibitor targeting vascular endothelial growth\nfactor and platelet-derived growth factor receptors: determination\nof a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"25","key":"2026091009074375800_cit33","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1021\/jm9904295","article-title":"Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones\nas inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases","volume":"42","author":"Sun","year":"1999","journal-title":"J. Med. Chem."},{"issue":"26","key":"2026091009074375800_cit34","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1021\/jm050680m","article-title":"(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines:\nplatelet-derived growth factor receptor tyrosine kinase inhibitors\nwith broad antiproliferative activity against tumor cells","volume":"48","author":"Ho","year":"2005","journal-title":"J. Med. Chem."},{"key":"2026091009074375800_cit35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2147\/OTT.S62946","article-title":"CP-673451, a platelet-derived growth-factor\nreceptor inhibitor, suppresses\nlung cancer cell proliferation and migration","volume":"7","author":"Xi","year":"2014","journal-title":"Oncol. Targets Ther."},{"key":"2026091009074375800_cit36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1570647","article-title":"Uncovering the heterogeneity of NK cells on the prognosis of HCC\nby integrating bulk and single-cell RNA-seq data","volume":"15","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"issue":"7","key":"2026091009074375800_cit37","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1021\/acs.jmedchem.1c01732","article-title":"Discovery of Potent and Orally Bioavailable\nPlatelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the\nTreatment of Osteosarcoma","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026091009074375800_cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215970","article-title":"Etomidate elicits anti-tumor capacity\nby disrupting the JAK2\/STAT3 signaling pathway in hepatocellular carcinoma","volume":"552","author":"Xu","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"2026091009074375800_cit39","first-page":"223","article-title":"MiR-1179 represses\ncell proliferation, migration and invasion of hepatocellular carcinoma\nthrough suppression of NUAK2","volume":"14","author":"Wang","year":"2022","journal-title":"Am. J. Transl.\nRes."},{"issue":"8","key":"2026091009074375800_cit40","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13641","article-title":"The role of Aurora kinase A in hepatocellular carcinoma:\nUnveiling the intriguing functions of a key but still underexplored\nfactor in liver cancer","volume":"57","author":"Grisetti","year":"2024","journal-title":"Cell Prolif."},{"issue":"1","key":"2026091009074375800_cit41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jhep.2009.10.013","article-title":"The selective\nAurora\nB kinase inhibitor AZD1152 as a novel treatment for hepatocellular\ncarcinoma","volume":"52","author":"Aihara","year":"2010","journal-title":"J. Hepatol."},{"key":"2026091009074375800_cit42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2021.11.005","article-title":"Inhibiting Src-mediated PARP1 tyrosine phosphorylation\nconfers synthetic\nlethality to PARP1 inhibition in HCC","volume":"526","author":"Sun","year":"2022","journal-title":"Cancer\nLett."},{"key":"2026091009074375800_cit43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.598855","article-title":"C-Kit, a Double-Edged\nSword in Liver Regeneration and Diseases","volume":"12","author":"Wang","year":"2021","journal-title":"Front.\nGenet."},{"issue":"3","key":"2026091009074375800_cit44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.gendis.2019.12.008","article-title":"Study on the hepatocellular\ncarcinoma model with metastasis","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis."},{"issue":"9","key":"2026091009074375800_cit45","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.15252\/emmm.201607315","article-title":"MG132-induced\nprogerin clearance is mediated by autophagy activation and splicing\nregulation","volume":"9","author":"Harhouri","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"2026091009074375800_cit46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.416","article-title":"Lysosomotropism\ndepends on glucose:\na chloroquine resistance mechanism","volume":"8","author":"Gallagher","year":"2017","journal-title":"Cell Death\nDis."},{"key":"2026091009074375800_cit47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115703","article-title":"Design, synthesis,\nand biological evaluation of 1,6-naphthyridine-2-one derivatives as\nnovel FGFR4 inhibitors for the treatment of colorectal cancer","volume":"259","author":"Fang","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c03028","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20091\/65847950\/acs.jmedchem.5c03028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20091\/65847950\/acs.jmedchem.5c03028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:14:18Z","timestamp":1789046058000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/17\/20091\/5204960\/Discovery-Optimization-and-Evaluation-of-Potent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":47,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,7,9]]},"published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03028","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}